Amelioration of inflammatory arthritis by targeting the pre-ligand assembly domain of tumor necrosis factor receptors.
Tumor necrosis factor (TNF)-alpha has an important role in the pathogenesis of autoimmune and inflammatory diseases such as rheumatoid and septic arthritis. The biological effects of TNF-alpha are mediated by binding to TNF receptors TNFR1 (also known as P60) or TNFR2 (also known as P80). The pre-ligand assembly domain (PLAD) is a portion of the extracellular region of TNFRs that mediates receptor-chain association essential for signaling. We found that soluble versions of PLAD, especially those derived from P60, block the biochemical effects of TNF-alpha in vitro and potently inhibit arthritis in animal models. Thus, targeting the PLAD may have clinical value in the treatment of human arthritis and other disorders involving receptors of the TNFR superfamily.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
DOI
ISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Recombinant Fusion Proteins
- Receptors, Tumor Necrosis Factor, Type II
- Receptors, Tumor Necrosis Factor, Type I
- Receptors, Tumor Necrosis Factor
- Protein Structure, Tertiary
- Mice, Transgenic
- Mice, Knockout
- Mice
- Ligands
Citation
Published In
DOI
ISSN
Publication Date
Volume
Issue
Start / End Page
Location
Related Subject Headings
- Tumor Necrosis Factor-alpha
- Recombinant Fusion Proteins
- Receptors, Tumor Necrosis Factor, Type II
- Receptors, Tumor Necrosis Factor, Type I
- Receptors, Tumor Necrosis Factor
- Protein Structure, Tertiary
- Mice, Transgenic
- Mice, Knockout
- Mice
- Ligands